Skip to main content
Caplight Logo









Nuritas

Nuritas

Private
DublinHealthcare & Life Scienceshttps://www.nuritas.com/

Last Round

Series C

Dec 20, 2024

Total Funding Raised

$146.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nuritas is a biotechnology company that utilizes a platform combining artificial intelligence and genomics to discover and unlock natural bioactive peptides for use in dietary supplements, functional foods, and cosmetics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

bioactive peptidesAI-powered discoveryfunctional ingredientspeptide discoveryfood techlongevity researchprecision nutritionnutraceuticalsAI drug discoverypeptide hydrolysatesbiotechingredient innovationclinical validationhealthy agingCPG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuritas Comparables

Compare Nuritas with similar companies based on industry and business-model similarity.

Nuritas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shiru
87%
Brightseed
83%
Protera
81%

Nuritas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 20, 2024
Series BNov 11, 2021
DebtNov 29, 2018
Series ADec 20, 2017
SeedDec 7, 2016
Seed
Oct 26, 2015

Key People

Founding team and executive leadership

John Casey

CEO

Executive Team

Nora K.

Founder, CEO

Founding Team

Alison Anderson MBA CIPD

Chief People Officer

Executive Team

Nuritas Investors

Notable investors and investment history

Nuritas investors
InvestorRounds
Cultivian Sandbox VenturesSeries B, Series A
Grosvenor Food & AgTechSeries C, Series B
McWin Capital PartnersSeries C
European Investment Bank GroupDebt
M&G InvestmentsSeries C
Cleveland AvenueSeries B
Clay CapitalSeries A, Seed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 36% MoM, from 12.4K to 16.9K.

  • May 5, 2026

    Exhibiting at Vitafoods Europe 2026 in Barcelona.

Recent news

Latest coverage and updates

  • hiresSep 10, 2026

    Nuritas hired Kees Kruythoff as Chair of Board of Directors on Sep 10th '26.

  • is_developingJul 24, 2026

    Nuritas Ltd is developing peptide ingredients for health, nutrition, and skin longevity..

  • attends_eventJul 6, 2026

    Nuritas Ltd attended event Summer Fancy Food Show 2026 on Jul 1st '26.

Nuritas Filings

Explore SEC and related filing metadata, where available.

Nuritas filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuritas's valuation, stock price, and market status.

Is Nuritas a public or private company?

Nuritas is a private company.

What is the current stock price of Nuritas?

Nuritas is a private company with no public stock price. No recent secondary market data is available.

How much is Nuritas worth (valuation)?

Valuation information for Nuritas is not publicly available.

Can I buy Nuritas stock?

Nuritas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuritas's last funding round?

Nuritas's most recent funding round was Series C on December 20, 2024.

Who are the main investors in Nuritas?

Key investors in Nuritas include Cultivian Sandbox Ventures, M&G Investments, Cleveland Avenue.

Will Nuritas IPO soon?

No public IPO plans have been announced for Nuritas.

How can I track Nuritas secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuritas's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range64
Year Founded2014
Last FundingDec 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?